<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Int Assoc Provid AIDS Care</journal-id><journal-id journal-id-type="iso-abbrev">J Int Assoc Provid AIDS Care</journal-id><journal-id journal-id-type="pmc-domain-id">3707</journal-id><journal-id journal-id-type="pmc-domain">jia</journal-id><journal-id journal-id-type="publisher-id">JIA</journal-id><journal-title-group><journal-title>Journal of the International Association of Providers of AIDS Care</journal-title></journal-title-group><issn pub-type="ppub">2325-9574</issn><issn pub-type="epub">2325-9582</issn><publisher><publisher-name>SAGE Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11078087</article-id><article-id pub-id-type="pmcid-ver">PMC11078087.1</article-id><article-id pub-id-type="pmcaid">11078087</article-id><article-id pub-id-type="pmcaiid">11078087</article-id><article-id pub-id-type="pmid">38715366</article-id><article-id pub-id-type="doi">10.1177/23259582241241169</article-id><article-id pub-id-type="publisher-id">10.1177_23259582241241169</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Current Perspectives in HIV and Aging</subject><subj-group subj-group-type="heading"><subject>Original Research Article</subject></subj-group></subj-group></article-categories><title-group><article-title>Prevalence of Frailty Phenotypes in Older People Living with HIV: A Cross-Sectional Study from Brazil</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Wiechmann</surname><given-names initials="SL">Susana Lilian</given-names></name><degrees>PhD</degrees><xref rid="aff1-23259582241241169" ref-type="aff">1</xref><xref rid="aff2-23259582241241169" ref-type="aff">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7083-9464</contrib-id><name name-style="western"><surname>Tejo</surname><given-names initials="AM">Alexandre Mestre</given-names></name><degrees>MD</degrees><xref rid="aff1-23259582241241169" ref-type="aff">1</xref><xref rid="corresp1-23259582241241169" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>In&#225;cio</surname><given-names initials="MVS">Manuel Victor Silva</given-names></name><degrees>MD</degrees><xref rid="aff1-23259582241241169" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mesas</surname><given-names initials="AE">Arthur Eumann</given-names></name><degrees>PhD</degrees><xref rid="aff2-23259582241241169" ref-type="aff">2</xref><xref rid="aff3-23259582241241169" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cabrera</surname><given-names initials="MAS">Marcos Aparecido Sarria</given-names></name><degrees>PhD</degrees><xref rid="aff2-23259582241241169" ref-type="aff">2</xref></contrib></contrib-group><aff id="aff1-23259582241241169">
<label>1</label>Division of Infectious Diseases, Internal Medicine Department, Universidade Estadual de Londrina, Londrina, Brazil</aff><aff id="aff2-23259582241241169">
<label>2</label>Postgraduate Program in Public Health, Universidade Estadual de Londrina, Londrina, Brazil</aff><aff id="aff3-23259582241241169">
<label>3</label>Health and Social Research Centre, <institution-wrap><institution-id institution-id-type="Ringgold">97010</institution-id><institution content-type="university">Universidad de Castilla-La Mancha</institution></institution-wrap>, Cuenca, Spain</aff><author-notes><corresp id="corresp1-23259582241241169">Alexandre Mestre Tejo, University Hospital of Londrina, Universidade Estadual de Londrina, P.O. Box: 86038-440, Londrina, Brazil. 
Email: <email>alexandre.tejo@uel.br</email></corresp></author-notes><pub-date pub-type="epub"><day>7</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><season>Jan-Dec</season><year>2024</year></pub-date><volume>23</volume><issue-id pub-id-type="pmc-issue-id">452635</issue-id><elocation-id>23259582241241169</elocation-id><history><date date-type="received"><day>10</day><month>10</month><year>2023</year></date><date date-type="rev-recd"><day>23</day><month>11</month><year>2023</year></date><date date-type="accepted"><day>2</day><month>3</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>07</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>08</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-09 10:25:16.560"><day>09</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder content-type="sage">SAGE Publications Inc. unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10.1177_23259582241241169.pdf"/><abstract><sec><title>Background</title><p>Frailty may affect people living with HIV (PLHIV) prematurely. Fried's frailty phenotype, composed of 5 criteria, is one of the most used instruments for its assessment. This study aimed to determine the prevalence of these criteria among PLHIV classified as prefrail and frail in Brazil.</p></sec><sec><title>Methods</title><p>A cross-sectional study analyzed the prevalence of the Frailty Phenotype in Brazil with 670 individuals aged&#8201;&#8805;&#8201;50 years and undetectable viral load.</p></sec><sec><title>Results</title><p>The prevalence of prefrail and frail individuals was 50.7% and 13.6%, respectively. A low level of physical activity was the most prevalent criterion (50.9%). Except for unintentional weight loss, all other criteria were more prevalent among individuals with lower education levels. All criteria were more prevalent among individuals of lower socioeconomic status than among those of moderate or high status (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.05).</p></sec><sec><title>Conclusions</title><p>A low level of physical activity was the component that most contributed to PLHIV being considered prefrail or frail.</p></sec></abstract><kwd-group><kwd>HIV</kwd><kwd>aging</kwd><kwd>physical activity</kwd><kwd>frailty</kwd><kwd>frailty phenotype criteria</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts19</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January-December 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="section1-23259582241241169"><title>Introduction</title><p>Frailty is a multisystemic condition often associated with aging, in which there is a decline in an individual's physical and functional reserve, leaving them vulnerable to stressful events<sup>
<xref rid="bibr1-23259582241241169" ref-type="bibr">1</xref>
</sup> and associated with a higher risk of serious health outcomes, such as falls, hospitalizations, disability, and death.<sup>
<xref rid="bibr1-23259582241241169" ref-type="bibr">1</xref>
</sup> People living with HIV (PLHIV) may be prematurely affected by frailty when compared to individuals in the general population.<sup>
<xref rid="bibr2-23259582241241169" ref-type="bibr">2</xref>
</sup></p><p>Several instruments in the literature assess frailty, however, Fried's frailty phenotype<sup>
<xref rid="bibr3-23259582241241169" ref-type="bibr">3</xref>
</sup> is the most widely used, both in research with the general population and in PLHIV.<sup><xref rid="bibr4-23259582241241169" ref-type="bibr">4</xref>,<xref rid="bibr5-23259582241241169" ref-type="bibr">5</xref></sup> In this instrument, individuals are evaluated according to the presence of 5 criteria: unintentional weight loss, self-reported exhaustion, slow gait, weakness, and low level of physical activity. The score obtained in each criterion results in the classification of individuals into three distinct groups: frail, prefrail, or robust.<sup>
<xref rid="bibr3-23259582241241169" ref-type="bibr">3</xref>
</sup></p><p>In a recent review of 26 studies that used Fried's phenotype,<sup>
<xref rid="bibr3-23259582241241169" ref-type="bibr">3</xref>
</sup> the combined prevalence of frailty and prefrailty among PLHIV aged &#8805;50 years was 10.9% (8.1%-14.2%) and 47.2% (40.1%-54.4%), respectively.<sup>
<xref rid="bibr6-23259582241241169" ref-type="bibr">6</xref>
</sup> However, few of these studies discriminate the prevalence of each of the 5 criteria that constitute the frailty phenotype.</p><p>Knowing the individual contribution of these criteria is important due to the dynamic nature of frailty.<sup>
<xref rid="bibr1-23259582241241169" ref-type="bibr">1</xref>
</sup> The transition from a state of robustness or prefrailty to frailty can be prevented or delayed by adopting measures targeted to specific components of the frailty phenotype.<sup>
<xref rid="bibr7-23259582241241169" ref-type="bibr">7</xref>
</sup> The objective of this study was to determine the prevalence of each of these components among PLHIV classified as prefrail and frail attended in specialized HIV/AIDS services in Brazil.</p></sec><sec sec-type="methods" id="section2-23259582241241169"><title>Methods</title><sec id="section2A-23259582241241169"><title>Study Design and Population</title><p>A cross-sectional study was conducted with PLHIV attended in the only two public services specialized in outpatient care for HIV/AIDS in a large municipality of Brazil. The study was conducted in 2 time periods, due to the COVID-19 pandemic: from November 2019 to March 2020 and from September 2020 to November 2021 and included all PLHIV aged &#8805;50 years, using antiretroviral therapy (ART), and with undetectable viral load from the 2 services. Individuals with active neoplasms, severe cognitive or psychiatric disorders, wheelchair users, and bedridden individuals were excluded from the study.</p></sec><sec id="section2B-23259582241241169"><title>Data Collection</title><p>Participants were interviewed to obtain sociodemographic, behavioral, and clinical data and underwent a physical assessment to measure weight, height, body mass index (BMI), and dental condition. Medical records were reviewed to verify comorbidities and history of antiretroviral use. CD4 and CD8 cell count and viral load were obtained from the national database.</p><p>The frailty phenotype was evaluated using the criteria suggested by Fried et al.<sup>
<xref rid="bibr3-23259582241241169" ref-type="bibr">3</xref>
</sup> Individuals with no positive criteria were classified as robust, those with 1 or 2 positive criteria were classified as prefrail, and those with 3 or more positive criteria were classified as frail.<sup>
<xref rid="bibr3-23259582241241169" ref-type="bibr">3</xref>
</sup> Weight loss was defined as the unintentional loss of &#8805;4.5&#8197;kg or &#8805;5% of body weight compared to the measurement recorded in the medical record in the last year. Two questions (No. 7 and No. 20) from the International Depression Questionnaire<sup>
<xref rid="bibr8-23259582241241169" ref-type="bibr">8</xref>
</sup> were used to evaluate self-reported exhaustion. Weakness, adjusted for sex and BMI, was evaluated by the mean obtained from three values of grip strength (kg) of the dominant hand using a Saehan<sup>&#174;</sup> dynamometer. Gait speed was evaluated by timing the seconds taken to walk the distance of 4.6 meters, adjusting the results for sex and height. Low level of physical activity was assessed through self-reported weekly caloric expenditure stratified by sex using the Minnesota Leisure-Time Physical Activity Questionnaire.<sup>
<xref rid="bibr9-23259582241241169" ref-type="bibr">9</xref>
</sup> The cutoff points used for muscle strength, gait speed, and physical activity were those previously determined by Fried et al.<sup>
<xref rid="bibr3-23259582241241169" ref-type="bibr">3</xref>
</sup></p><p>The sociodemographic and behavioral variables included sex, age, education level, economic class, smoking, alcohol consumption, and illicit drug use. The following comorbidities were evaluated: depression, diabetes, dyslipidemia, cardiovascular diseases, thyroid disease, chronic pain, chronic obstructive pulmonary disease, chronic kidney disease, and systemic arterial hypertension. Multimorbidity<sup>
<xref rid="bibr10-23259582241241169" ref-type="bibr">10</xref>
</sup> was defined as the presence of two or more of the abovementioned comorbidities, except depression. Polypharmacy was defined as the use of five or more medications, except for ART.<sup>
<xref rid="bibr11-23259582241241169" ref-type="bibr">11</xref>
</sup></p><p>Functional dentition was defined as &#8804;20 teeth present.<sup>
<xref rid="bibr12-23259582241241169" ref-type="bibr">12</xref>
</sup> Cognitive capacity was assessed through questions that addressed subjective complaints of cognitive decline<sup>
<xref rid="bibr13-23259582241241169" ref-type="bibr">13</xref>
</sup> and by the Mini-Mental State Examination (MMSE).<sup>
<xref rid="bibr14-23259582241241169" ref-type="bibr">14</xref>
</sup> Participants in the study were also evaluated for a history of falls (&#8805;2 falls) and hospitalizations in the last 12&#8197;months.</p><p>Parameters related to HIV included time of diagnosis, CD4, and CD8 cell counts, and CD4/CD8 ratio. Regarding ART, the duration of use, history of treatment adherence, and the number of ART regimens used were evaluated.</p></sec><sec id="section2C-23259582241241169"><title>Statistical Analysis</title><p>Initially, the study population was characterized according to sociodemographic, lifestyle, health, and HIV-related variables in total and concerning each of the 5 criteria of the frailty phenotype. The association with each criterion was tested for categorical variables using the chi-square test and for quantitative variables using the nonparametric Mann&#8211;Whitney test.</p><p>In sequence, the prevalence of prefrailty and frailty for the total study population was determined, and the prevalence of each criterion was calculated among prefrail and frail individuals and stratified by sex, age group (&lt; 60 and&#8201;&#8805;&#8201;60 years), educational level (low and moderate/high), and socioeconomic status (low and moderate/high), using the chi-square test to detect differences in the proportion of individuals who met the criterion in each subgroup.</p><p>Finally, radial graphs were used to represent the frequency of each criterion among prefrail and frail individuals according to sex and age group. The significance level adopted for all tests was 5%. All analyses were performed using the IBM SPSS Statistics 28.0 computer program.</p></sec></sec><sec id="section3-23259582241241169"><title>Ethical Approval, Informed Consent, and Registration</title><p>The study was approved by the Human Research Ethics Committee, no. 3.558.689. Written consent was obtained from all participants. As an observational cohort, this study was not registered, and the study protocol has not been previously published.</p></sec><sec sec-type="results" id="section4-23259582241241169"><title>Results</title><p>From the 670 individuals who participated in this study, 239 (35.7%) did not score in any of the criteria and were considered robust, 340 (50.7%) scored in 1 or 2 criteria and were classified as prefrail, and 91 (13.6%) scored in 3 or more criteria and were considered frail.</p><p>Overall, a low level of physical activity (50.9%) was the most prevalent criterion, followed by self-reported exhaustion (28.1%), weakness (24.0%), weight loss (6.6%), and slow gait (6.3%). A low level of physical activity was present in 98.9% of frail individuals and 73.8% of prefrail individuals. Moreover, among the 206 individuals who scored in only one criterion, a low level of physical activity was also the most prevalent component (66.5%). Among frail individuals, weight loss was the least prevalent criterion (26.4%), and among prefrail individuals, slow gait was the least scored criterion (2.1%) (<xref rid="fig1-23259582241241169" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="fig1-23259582241241169" orientation="portrait"><label>Figure 1.</label><caption><p>Prevalence of each frailty phenotype criterion.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_23259582241241169-fig1.jpg"/></fig><p>The median age was 58 years old, and the majority of participants were male (55.7%). <xref rid="fig2-23259582241241169" ref-type="fig">Figure 2</xref> shows the prevalence of each criterion according to sociodemographic variables. Self-reported exhaustion, slow gait, and low levels of physical activity were more prevalent among women than among men (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.05). A higher prevalence of weakness, slow gait, and low level of physical activity was observed among individuals aged 60 years or older compared to those younger (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.05). Except for weight loss, all other criteria were more prevalent among individuals with lower education levels than among those with higher. Regarding economic class, all criteria were more prevalent among individuals from lower economic classes than among those from moderate or high classes (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.05).</p><fig position="float" id="fig2-23259582241241169" orientation="portrait"><label>Figure 2.</label><caption><p>Prevalence of each frailty phenotype criterion by sociodemographic variables.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_23259582241241169-fig2.jpg"/></fig><p><xref rid="table1-23259582241241169" ref-type="table">Table 1</xref> provides descriptive data on the study population according to each of the 5 criteria investigated. Smokers had a higher prevalence of weight loss, self-reported exhaustion, and muscular weakness than nonsmokers. Frequent alcohol consumption was unrelated to any of the criteria, and illicit drug use was more prevalent among those with self-reported exhaustion.</p><table-wrap position="float" id="table1-23259582241241169" orientation="portrait"><label>Table 1.</label><caption><p>Characteristics of the Study Population According to the Frailty Phenotype Criteria.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_23259582241241169-table1.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">Total</th><th align="center" rowspan="1" colspan="1">Unintentional 
weight loss</th><th align="center" rowspan="1" colspan="1">Self-reported exhaustion</th><th align="center" rowspan="1" colspan="1">Weakness</th><th align="center" rowspan="1" colspan="1">Slow gait</th><th align="center" rowspan="1" colspan="1">Low physical activity</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Total</td><td rowspan="1" colspan="1">670 (100.0)</td><td rowspan="1" colspan="1">44 (6.6)</td><td rowspan="1" colspan="1">188 (28.1)</td><td rowspan="1" colspan="1">161 (24.0)</td><td rowspan="1" colspan="1">42 (6.3)</td><td rowspan="1" colspan="1">341 (50.9)</td></tr><tr><td rowspan="1" colspan="1">Tobacco smoker</td><td rowspan="1" colspan="1">175 (26.1)</td><td rowspan="1" colspan="1">18 (40.9)*</td><td rowspan="1" colspan="1">67 (35.6)**</td><td rowspan="1" colspan="1">55 (34.2)*</td><td rowspan="1" colspan="1">15 (35.7)</td><td rowspan="1" colspan="1">94 (27.6)</td></tr><tr><td rowspan="1" colspan="1">Alcoholic beverages drinker</td><td rowspan="1" colspan="1">43 (6.4)</td><td rowspan="1" colspan="1">3 (6.8)</td><td rowspan="1" colspan="1">14 (7.4)</td><td rowspan="1" colspan="1">15 (9.3)</td><td rowspan="1" colspan="1">2 (4.8)</td><td rowspan="1" colspan="1">27 (7.9)</td></tr><tr><td rowspan="1" colspan="1">Current illicit drugs user</td><td rowspan="1" colspan="1">24 (3.6)</td><td rowspan="1" colspan="1">2 (4.5)</td><td rowspan="1" colspan="1">12 (6.4)*</td><td rowspan="1" colspan="1">4 (2.5)</td><td rowspan="1" colspan="1">1 (2.4)</td><td rowspan="1" colspan="1">11 (3.2)</td></tr><tr><td rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>), median (IQR)</td><td rowspan="1" colspan="1">25.3 (22.5; 28.5)</td><td rowspan="1" colspan="1"> 20.9 (19.2;24.4)**</td><td rowspan="1" colspan="1">25.6 (22;29.1)</td><td rowspan="1" colspan="1">25.4 (21.4;30)</td><td rowspan="1" colspan="1">24.4 (19.7, 30.9)</td><td rowspan="1" colspan="1">25.5 (22.4, 29.3)</td></tr><tr><td rowspan="1" colspan="1">Multimorbidity (&#8805;2 chronic disease)</td><td rowspan="1" colspan="1">300 (44.8)</td><td rowspan="1" colspan="1">21 (47.7)</td><td rowspan="1" colspan="1">106 (56.4)**</td><td rowspan="1" colspan="1">93 (57.8)**</td><td rowspan="1" colspan="1">30 (71.4)**</td><td rowspan="1" colspan="1">185 (54.3)**</td></tr><tr><td rowspan="1" colspan="1">&#8195;Diabetes</td><td rowspan="1" colspan="1">123 (18.4)</td><td rowspan="1" colspan="1">7 (15.9)</td><td rowspan="1" colspan="1">38 (20.2)</td><td rowspan="1" colspan="1">43 (26.7)*</td><td rowspan="1" colspan="1">11 (26.2)</td><td rowspan="1" colspan="1">78 (22.9)*</td></tr><tr><td rowspan="1" colspan="1">&#8195;Dyslipidemia</td><td rowspan="1" colspan="1">450 (67.2)</td><td rowspan="1" colspan="1">24 (54.5)</td><td rowspan="1" colspan="1">128 (68.6)</td><td rowspan="1" colspan="1">103 (64.0)</td><td rowspan="1" colspan="1">30 (71.4)</td><td rowspan="1" colspan="1">246* (72.1)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Cardiovascular disease</td><td rowspan="1" colspan="1">58 (8.7)</td><td rowspan="1" colspan="1">8 (18.2)*</td><td rowspan="1" colspan="1">24 (12.8)*</td><td rowspan="1" colspan="1">26 (16.1)**</td><td rowspan="1" colspan="1">10 (23.8)**</td><td rowspan="1" colspan="1">42 (12.3)**</td></tr><tr><td rowspan="1" colspan="1">&#8195;Hypertension</td><td rowspan="1" colspan="1">245 (36.6)</td><td rowspan="1" colspan="1">19 (43.2)</td><td rowspan="1" colspan="1">79 (42.0)</td><td rowspan="1" colspan="1">76 (47.2)*</td><td rowspan="1" colspan="1">20 (47.6)</td><td rowspan="1" colspan="1">142 (41.6)*</td></tr><tr><td rowspan="1" colspan="1">&#8195;Chronic kidney disease</td><td rowspan="1" colspan="1">31 (4.6)</td><td rowspan="1" colspan="1">3 (6.8)</td><td rowspan="1" colspan="1">11 (5.9)</td><td rowspan="1" colspan="1">10 (6.2)</td><td rowspan="1" colspan="1">4 (9.5)</td><td rowspan="1" colspan="1">19 (5.6)</td></tr><tr><td rowspan="1" colspan="1">&#8195;COPD</td><td rowspan="1" colspan="1">14 (2.1)</td><td rowspan="1" colspan="1">2 (4.5)</td><td rowspan="1" colspan="1">9 (4.8)*</td><td rowspan="1" colspan="1">6 (3.7)</td><td rowspan="1" colspan="1">3 (7.1)*</td><td rowspan="1" colspan="1">8 (2.3)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Chronic pain</td><td rowspan="1" colspan="1">76 (11.3)</td><td rowspan="1" colspan="1">8 (18.2)</td><td rowspan="1" colspan="1">43 (22.9)**</td><td rowspan="1" colspan="1">33 (20.5)**</td><td rowspan="1" colspan="1">15 (35.7)**</td><td rowspan="1" colspan="1">56 (16.4)**</td></tr><tr><td rowspan="1" colspan="1">&#8195;Thyroid disease</td><td rowspan="1" colspan="1">51 (7.6)</td><td rowspan="1" colspan="1">3 (6.8)</td><td rowspan="1" colspan="1">21 (11.2)*</td><td rowspan="1" colspan="1">16 (9.9)</td><td rowspan="1" colspan="1">6 (14.3)</td><td rowspan="1" colspan="1">32 (9.4)</td></tr><tr><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">117 (17.5)</td><td rowspan="1" colspan="1">11 (25.0)</td><td rowspan="1" colspan="1">66 (33.5)**</td><td rowspan="1" colspan="1">35 (21.7)</td><td rowspan="1" colspan="1">7 (16.7)</td><td rowspan="1" colspan="1">72 (21.1)*</td></tr><tr><td rowspan="1" colspan="1">Polypharmacy</td><td rowspan="1" colspan="1">76 (11.3)</td><td rowspan="1" colspan="1">6 (13.6)</td><td rowspan="1" colspan="1">34 (18.1)*</td><td rowspan="1" colspan="1">31 (19.3)**</td><td rowspan="1" colspan="1">9 (21.4)*</td><td rowspan="1" colspan="1">58 (17.0)**</td></tr><tr><td rowspan="1" colspan="1">Subjective cognitive complaints</td><td rowspan="1" colspan="1">134 (20.0)</td><td rowspan="1" colspan="1">20 (45.5)**</td><td rowspan="1" colspan="1">80 (42.6)**</td><td rowspan="1" colspan="1">47 (29.2)*</td><td rowspan="1" colspan="1">14 (33.3)*</td><td rowspan="1" colspan="1">90 (26.4)**</td></tr><tr><td rowspan="1" colspan="1">MMSE, median (IQR)</td><td rowspan="1" colspan="1">28 (26; 29)</td><td rowspan="1" colspan="1">26.5 (25, 28)*</td><td rowspan="1" colspan="1">27.5 (25, 29)**</td><td rowspan="1" colspan="1">27 (24, 28)**</td><td rowspan="1" colspan="1">26 (20.8, 28)**</td><td rowspan="1" colspan="1">28 (25, 29)**</td></tr><tr><td rowspan="1" colspan="1">Use of dental prosthesis</td><td rowspan="1" colspan="1">326 (48.7)</td><td rowspan="1" colspan="1">23 (52.3)</td><td rowspan="1" colspan="1">96 (51.1)</td><td rowspan="1" colspan="1">100 (62.1)**</td><td rowspan="1" colspan="1">31 (73.8)*</td><td rowspan="1" colspan="1">182 (53.4)*</td></tr><tr><td rowspan="1" colspan="1">Absence of functional dentition (&#8804; 20 teeth)</td><td rowspan="1" colspan="1">408 (60.9)</td><td rowspan="1" colspan="1">31 (70.5)</td><td rowspan="1" colspan="1">125 (66.5)</td><td rowspan="1" colspan="1">127 (78.9)**</td><td rowspan="1" colspan="1">38 (90.5)**</td><td rowspan="1" colspan="1">222 (65.1)*</td></tr><tr><td rowspan="1" colspan="1">Falls (&#8805;2)</td><td rowspan="1" colspan="1">43 (6.4)</td><td rowspan="1" colspan="1">6 (13.6)*</td><td rowspan="1" colspan="1">24 (12.8)**</td><td rowspan="1" colspan="1">21 (13.0)**</td><td rowspan="1" colspan="1">9 (21.4)**</td><td rowspan="1" colspan="1">32 (9.4)*</td></tr><tr><td rowspan="1" colspan="1">Hospitalizations</td><td rowspan="1" colspan="1">48 (7.2)</td><td rowspan="1" colspan="1">9 (20.5)**</td><td rowspan="1" colspan="1">25 (13.3)**</td><td rowspan="1" colspan="1">27 (16.8)**</td><td rowspan="1" colspan="1">9 (21.4)**</td><td rowspan="1" colspan="1">36 (10.6)*</td></tr><tr><td rowspan="1" colspan="1">Age at diagnosis &#8805;50 Y</td><td rowspan="1" colspan="1">230 (34.3)</td><td rowspan="1" colspan="1">18 (40.9)</td><td rowspan="1" colspan="1">61 (32.4)</td><td rowspan="1" colspan="1">74 (46.0)**</td><td rowspan="1" colspan="1">22 (52.4)*</td><td rowspan="1" colspan="1">130 (38.1)*</td></tr><tr><td rowspan="1" colspan="1">Time since HIV diagnosis (Y), median (IQR)</td><td rowspan="1" colspan="1">13 (7, 20)</td><td rowspan="1" colspan="1">13 (8.3, 23)</td><td rowspan="1" colspan="1">14 (7, 20.8)</td><td rowspan="1" colspan="1">12 (6, 20)</td><td rowspan="1" colspan="1">14 (9.8, 19.3)</td><td rowspan="1" colspan="1">13 (97, 21)</td></tr><tr><td rowspan="1" colspan="1">AIDS history</td><td rowspan="1" colspan="1">401 (59.9)</td><td rowspan="1" colspan="1">25 (56.8)</td><td rowspan="1" colspan="1">108 (57.4)</td><td rowspan="1" colspan="1">92 (57.1)</td><td rowspan="1" colspan="1">23 (54.8)</td><td rowspan="1" colspan="1">201 (58.9)</td></tr><tr><td rowspan="1" colspan="1">Current CD4+ cell counts, median (IQR)</td><td rowspan="1" colspan="1">627 (453, 819)</td><td rowspan="1" colspan="1">652 (506, 890)</td><td rowspan="1" colspan="1">646 (458, 820)</td><td rowspan="1" colspan="1">590 (430, 790)</td><td rowspan="1" colspan="1">588 (411, 792)</td><td rowspan="1" colspan="1">645 (451, 820)</td></tr><tr><td rowspan="1" colspan="1">CD4+ cell NADIR &lt;200</td><td rowspan="1" colspan="1">381 (56.9)</td><td rowspan="1" colspan="1">23 (52.3)</td><td rowspan="1" colspan="1">109 (58.0)</td><td rowspan="1" colspan="1">94 (58.4)</td><td rowspan="1" colspan="1">24 (57.1)</td><td rowspan="1" colspan="1">187 (54.8)</td></tr><tr><td rowspan="1" colspan="1">CD4+/CD8+ ratio, median (IQR)</td><td rowspan="1" colspan="1">0.7 (0.5, 1.0)</td><td rowspan="1" colspan="1">0.8 (0.5, 1.1)</td><td rowspan="1" colspan="1">0.6 (0.4, 1.0)</td><td rowspan="1" colspan="1">0.6 (0.4, 0.9)</td><td rowspan="1" colspan="1">0.6 (0.4, 1.1)</td><td rowspan="1" colspan="1">0.7 (0.5, 1.0)</td></tr><tr><td rowspan="1" colspan="1">Time on art (Y), median (IQR)</td><td rowspan="1" colspan="1">10 (6, 17.3)</td><td rowspan="1" colspan="1">11.5 (8, 19.3)</td><td rowspan="1" colspan="1">11.5 (5, 17)</td><td rowspan="1" colspan="1">10 (5, 17.5)</td><td rowspan="1" colspan="1">12 (7.3, 16.3)</td><td rowspan="1" colspan="1">11 (6, 18.5)</td></tr><tr><td rowspan="1" colspan="1">History of low adherence to art</td><td rowspan="1" colspan="1">219 (32.7)</td><td rowspan="1" colspan="1">12 (27.3)</td><td rowspan="1" colspan="1">72 (38.3)</td><td rowspan="1" colspan="1">61 (37.9)</td><td rowspan="1" colspan="1">20 (47.6)*</td><td rowspan="1" colspan="1">128 (37.5)*</td></tr><tr><td rowspan="1" colspan="1">Antiretroviral regimens&#8201;&#8805;&#8201;5</td><td rowspan="1" colspan="1">111 (16.6)</td><td rowspan="1" colspan="1">4 (9.1)</td><td rowspan="1" colspan="1">29 (15.4)</td><td rowspan="1" colspan="1">26 (16.1)</td><td rowspan="1" colspan="1">6 (14.3)</td><td rowspan="1" colspan="1">62 (18.2)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-23259582241241169"><p>MMSE, mini-mental state examination; ART, antiretroviral treatment; COPD, chronic obstructive pulmonary disease; IQR, interquartile range.</p></fn><fn id="table-fn2-23259582241241169"><p>* <italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.050 e ** <italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.001.</p></fn></table-wrap-foot></table-wrap><p>Although hypertension was the most frequent comorbidity, it was not associated with a higher prevalence of any of the criteria. On the other hand, cardiovascular disease (8.7%) was associated with all components of the frailty phenotype. Except for weight loss, all other criteria were more prevalent among individuals with multimorbidity and polypharmacy. The absence of functional dentition and the use of dental prostheses were more prevalent among individuals with weakness, slow gait, and low physical activity. All criteria were more prevalent among individuals with subjective cognitive complaints, lower scores on the MMSE, those who had fallen, and those who had been hospitalized in the last year (<xref rid="table1-23259582241241169" ref-type="table">Table 1</xref>).</p><p>A higher prevalence of muscular weakness and low level of physical activity was observed among individuals diagnosed with HIV aged 50 years or older. Among those with a history of low adherence to ART, a higher prevalence of slow gait and low levels of physical activity was observed (<xref rid="table1-23259582241241169" ref-type="table">Table 1</xref>).</p><sec id="section4A-23259582241241169"><title>Parte inferior do Formul&#225;rio</title><p><xref rid="fig3-23259582241241169" ref-type="fig">Figures 3</xref> and <xref rid="fig4-23259582241241169" ref-type="fig">4</xref> demonstrate the prevalence of criteria by sex and age, respectively. Low levels of physical activity and self-reported exhaustion were the most prevalent criteria in frail individuals of both sexes and age groups. Muscular weakness was the criterion that most contributed to differentiating frail men from frail women. Regarding prefrailty, the prevalence of criteria was similar for both sexes (<xref rid="fig3-23259582241241169" ref-type="fig">Figure 3</xref>). Slow gait was the criterion that most contributed to differentiating frail individuals aged&#8201;&#8805;&#8201;60 years from those aged&#8201;&lt;&#8201;60 years. On the other hand, among prefrail individuals, the prevalence of criteria was similar for both age groups (<xref rid="fig4-23259582241241169" ref-type="fig">Figure 4</xref>).</p><fig position="float" id="fig3-23259582241241169" orientation="portrait"><label>Figure 3.</label><caption><p>Prevalence of the frailty phenotype criteria according to gender.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_23259582241241169-fig3.jpg"/></fig><fig position="float" id="fig4-23259582241241169" orientation="portrait"><label>Figure 4.</label><caption><p>Prevalence of the frailty phenotype criteria according to age group.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_23259582241241169-fig4.jpg"/></fig></sec></sec><sec sec-type="discussion" id="section5-23259582241241169"><title>Discussion</title><p>The present epidemiological study identified, in a large sample of PLHIV, a prevalence of prefrailty of 50.7% and frailty of 13.6%. When analyzing the individual prevalence of the criteria considered for this classification, a low level of physical activity was the most prevalent component, being observed in over half of the surveyed individuals (50.9%), followed by self-reported exhaustion (28.1%) and weakness (24.0%). Unintentional weight loss (6.6%) and slow gait (6.3%) were the least prevalent criteria. The low level of physical activity criterion had the highest number of associations with the researched variables, while unintentional weight loss had the lowest number.</p><p>An individual analysis of the criteria demonstrates that they vary in their frequency of distribution and present different associations with various risk factors and adverse events such as falls, hospitalizations, and death.<sup><xref rid="bibr1-23259582241241169" ref-type="bibr">1</xref>,<xref rid="bibr4-23259582241241169" ref-type="bibr">4</xref>,<xref rid="bibr15-23259582241241169" ref-type="bibr">15</xref>-<xref rid="bibr17-23259582241241169" ref-type="bibr">17</xref></sup> Furthermore, there seems to be an order to the appearance of the criteria during the progression to frailty, starting with weakness, slow gait, and low level of physical activity and culminating in self-reported exhaustion and unintentional weight loss.<sup>
<xref rid="bibr1-23259582241241169" ref-type="bibr">1</xref>
</sup></p><p>According to Fried et al,<sup>
<xref rid="bibr3-23259582241241169" ref-type="bibr">3</xref>
</sup> the prevalence of each criterion among individuals in the general North American population aged 65 or older was 22% for low physical activity, 20% for slow gait, 20% for weakness, 17% for self-reported exhaustion, and 6% for unintentional weight loss.<sup>
<xref rid="bibr3-23259582241241169" ref-type="bibr">3</xref>
</sup> In Brazil, a survey with people in the general population aged &#8805;50 observed a higher prevalence of self-reported exhaustion (28.6%), weakness (22.6%), slow gait (20.5%), low level of physical activity (19.8%), and unintentional weight loss (7.4%).<sup>
<xref rid="bibr18-23259582241241169" ref-type="bibr">18</xref>
</sup></p><p>In previous studies with PLHIV, some reported low levels of physical activity as the most prevalent component,<sup><xref rid="bibr19-23259582241241169" ref-type="bibr">19</xref>-<xref rid="bibr24-23259582241241169" ref-type="bibr">24</xref></sup> others reported exhaustion,<sup><xref rid="bibr16-23259582241241169" ref-type="bibr">16</xref>,<xref rid="bibr25-23259582241241169" ref-type="bibr">25</xref>,<xref rid="bibr26-23259582241241169" ref-type="bibr">26</xref></sup> and others reported weakness.<sup><xref rid="bibr27-23259582241241169" ref-type="bibr">27</xref>-<xref rid="bibr30-23259582241241169" ref-type="bibr">30</xref></sup> Moreover, some studies reported no differences in the prevalence of frailty components between PLHIV and individuals from the general population,<sup><xref rid="bibr31-23259582241241169" ref-type="bibr">31</xref>,<xref rid="bibr32-23259582241241169" ref-type="bibr">32</xref></sup> while significant differences were reported in others.<sup><xref rid="bibr16-23259582241241169" ref-type="bibr">16</xref>,<xref rid="bibr29-23259582241241169" ref-type="bibr">29</xref></sup></p><p>However, most frailty research uses adapted or modified versions of the frailty phenotype,<sup><xref rid="bibr6-23259582241241169" ref-type="bibr">6</xref>,<xref rid="bibr33-23259582241241169" ref-type="bibr">33</xref></sup> often changing the way each criterion is measured and, as a result, altering their prevalence and making data comparisons between studies more difficult.<sup>
<xref rid="bibr33-23259582241241169" ref-type="bibr">33</xref>
</sup> Low levels of physical activity and weight loss are the criteria that undergo the most modifications.<sup>
<xref rid="bibr33-23259582241241169" ref-type="bibr">33</xref>
</sup> In fact, Ziller et al<sup>
<xref rid="bibr34-23259582241241169" ref-type="bibr">34</xref>
</sup> found that, between 5 different tools to assess physical activity, the prevalence of frailty in the same population ranged from 14.9% to 31.9%.</p><p>In this study, physical activity was evaluated as originally proposed by Fried et al,<sup>
<xref rid="bibr3-23259582241241169" ref-type="bibr">3</xref>
</sup> through the Minnesota Leisure-Time Physical Activity Questionnaire.<sup>
<xref rid="bibr9-23259582241241169" ref-type="bibr">9</xref>
</sup> However some authors question its applicability for assessing physical activity in older adults, since it was originally designed to evaluate young, healthy, male individuals,<sup>
<xref rid="bibr33-23259582241241169" ref-type="bibr">33</xref>
</sup> the low level of physical activity found in this study was higher than that reported in previous studies with a similar population,<sup>
<xref rid="bibr24-23259582241241169" ref-type="bibr">24</xref>
</sup> and support previous data showing that the level of sedentary behavior among PLHIV is high<sup>
<xref rid="bibr35-23259582241241169" ref-type="bibr">35</xref>
</sup> and greater among women than men.<sup>
<xref rid="bibr36-23259582241241169" ref-type="bibr">36</xref>
</sup></p><p>Self-reported exhaustion or fatigue is a common symptom in PLHIV, even among those on ART with good disease control,<sup>
<xref rid="bibr37-23259582241241169" ref-type="bibr">37</xref>
</sup> and is often associated with anxiety and depression.<sup>
<xref rid="bibr38-23259582241241169" ref-type="bibr">38</xref>
</sup> As a self-reported criterion, its prevalence may be overestimated when including individuals with depressive symptoms.<sup>
<xref rid="bibr3-23259582241241169" ref-type="bibr">3</xref>
</sup> However, the exclusion of these individuals from studies that use the frailty phenotype is still a controversial topic.<sup>
<xref rid="bibr33-23259582241241169" ref-type="bibr">33</xref>
</sup> In the study by Koji et al,<sup>
<xref rid="bibr32-23259582241241169" ref-type="bibr">32</xref>
</sup> self-reported exhaustion was the most prevalent criterion and the authors observed that depression, although strongly associated with frailty, was not sufficient to explain the higher prevalence of frail and prefrail individuals among PLHIV, compared to the general population. Therefore, in agreement with other authors, this study chose not to exclude individuals with a previous diagnosis of depression.</p><p>In the general population, handgrip strength increases until adulthood and begins to decline rapidly from the age of 60, due to changes in body composition, such as loss of muscle mass and sarcopenia.<sup>
<xref rid="bibr39-23259582241241169" ref-type="bibr">39</xref>
</sup> PLHIV has a higher risk of developing this condition.<sup>
<xref rid="bibr40-23259582241241169" ref-type="bibr">40</xref>
</sup> A previous study showed that men living with HIV, notably those who remained with detectable viral load for a longer time, had a faster decline in handgrip strength after the age of 50 and had about 10 years earlier occurrence of weakness, compared to men of the same age without infection.<sup>
<xref rid="bibr41-23259582241241169" ref-type="bibr">41</xref>
</sup> In addition, the decline in muscle strength and gait speed was also pointed out in a previous study as the factor most associated with frailty among PLHIV.<sup>
<xref rid="bibr15-23259582241241169" ref-type="bibr">15</xref>
</sup> In this study, the criterion of weakness contributed to differentiating frail men from frail women and is consistent with a previous study that demonstrated that the reduction of muscle strength among PLHIV on ART was more evident among men than women.<sup>
<xref rid="bibr42-23259582241241169" ref-type="bibr">42</xref>
</sup></p><sec id="section5A-23259582241241169"><title>Parte inferior do Formul&#225;rio</title><p>Unintentional weight loss is considered the least informative component among the 5 frailty criteria<sup>
<xref rid="bibr4-23259582241241169" ref-type="bibr">4</xref>
</sup> and one of the lowest prevalent components in studies with PLHIV.<sup><xref rid="bibr26-23259582241241169" ref-type="bibr">26</xref>,<xref rid="bibr28-23259582241241169" ref-type="bibr">28</xref>,<xref rid="bibr30-23259582241241169" ref-type="bibr">30</xref></sup> In the general older population, unintentional weight loss was the criterion that appeared later, detected a few years before the diagnosis of frailty and related events.<sup>
<xref rid="bibr1-23259582241241169" ref-type="bibr">1</xref>
</sup> Moreover, previously described as one of the main symptoms related to advanced HIV infection, weight loss among PLHIV is now less observed as a result of early treatment. In fact, an increased number of PLHIV on ART are overweight or obese<sup>
<xref rid="bibr43-23259582241241169" ref-type="bibr">43</xref>
</sup> corroborating the findings of this study, with more than half of the individuals overweighted or obese.</p><p>Slow gait is the main frailty indicator in the general older population and the most predictive phenotype criterion of health-related adverse events.<sup><xref rid="bibr4-23259582241241169" ref-type="bibr">4</xref>,<xref rid="bibr17-23259582241241169" ref-type="bibr">17</xref></sup> Among PLHIV, the gait speed declines with age and settles earlier and faster than in the general population.<sup>
<xref rid="bibr44-23259582241241169" ref-type="bibr">44</xref>
</sup> In this study, although it was the least observed criterion, slow gait contributed the most to differentiating older frail individuals from younger frail individuals.</p><p>This research showed the association of frailty phenotype criteria with different sociodemographic, behavioral, clinical, and HIV- and ART-related factors. Some of these associations were also observed in previous studies and reinforce the multifactorial nature of frailty<sup>
<xref rid="bibr5-23259582241241169" ref-type="bibr">5</xref>
</sup> and the need for a broader evaluation of older PLHIV who are in regular use of ART, focusing less on the virus and more on promoting overall health.<sup>
<xref rid="bibr45-23259582241241169" ref-type="bibr">45</xref>
</sup> Indeed, as observed in this study and previous studies,<sup><xref rid="bibr27-23259582241241169" ref-type="bibr">27</xref>,<xref rid="bibr30-23259582241241169" ref-type="bibr">30</xref></sup> frailty in PLHIV with good virological control is less related to specific virus-related factors and more associated with factors found in the general population.</p><p>One of the main measures to prevent or delay the progression to frailty is to act on sedentarism. Regular physical activity, associated with nutritional supplementation when indicated, has a modifying action on various frailty phenotype criteria and is considered the intervention with the best results.<sup>
<xref rid="bibr7-23259582241241169" ref-type="bibr">7</xref>
</sup> The data from this study show that women, people aged &#8805;60 years, and those with worse socioeducational conditions should be seen as priority groups for this type of intervention.</p><p>In the assessment of cognitive status, each participant was first asked about their perception of their current cognitive ability and then the MMSE test was applied. Both items were significantly associated with prefrail and frail individuals. In a study by Hsieh et al,<sup>
<xref rid="bibr46-23259582241241169" ref-type="bibr">46</xref>
</sup> with elderly people from the general population, subjective cognitive decline was a factor independently associated with frailty. The present study, therefore, corroborates this finding also among PLHIV and indicates that evaluation of this variable can be another tool for screening for frailty among PLHIV.</p><p>Currently, the health services that provide care to PLHIV need to adapt to the new context provided by the aging of this population.<sup>
<xref rid="bibr45-23259582241241169" ref-type="bibr">45</xref>
</sup> To meet all the demands resulting from the various potential frailty-related factors, the most appropriate approach is through a multidisciplinary team,<sup>
<xref rid="bibr47-23259582241241169" ref-type="bibr">47</xref>
</sup> consisting of an infectious disease physician, geriatrician, nursing team, physiotherapist, psychologist, social worker, pharmacist, dentist, among others. Thus, to provide comprehensive care, it is necessary for the health service to provide conditions for the individual to quit smoking and the use of other drugs, encourage the prevention and adequate control of comorbidities, reevaluate the medications in use, and adjust to reduce polypharmacy, and offer evaluation and follow-up of mental and oral health.</p><p>The study has some limitations. The COVID-19 pandemic may have influenced some of the results. Despite the research being able to reach 85.6% of those eligible, individuals primarily excluded and those who were not recruited may have reduced their visits to healthcare services precisely because they were more debilitated. Additionally, some of the participants were approached during the local government's measures to contain the viral infection. Such measures, such as travel restrictions and the closure of clubs and gyms, may have favored social isolation, the emergence of depressive symptoms, and a reduction in caloric expenditure among this population, altering the prevalence of some components of the frailty phenotype. An increase in the prevalence of frailty was observed in a recent study conducted with elderly individuals from the general population of European countries that adopted confinement measures to contain the COVID-19 pandemic.<sup>
<xref rid="bibr48-23259582241241169" ref-type="bibr">48</xref>
</sup></p></sec></sec><sec sec-type="conclusions" id="section6-23259582241241169"><title>Conclusions</title><p>Low levels of physical activity contributed to frailty or prefrailty in PLHIV in this study. Therefore, measures directed toward this criterion, such as promoting regular physical activity and exercise, could improve this population's frailty status, especially for individuals classified as prefrail. Furthermore, the prevalence distribution of the components of the frailty phenotype may vary between men and women living with HIV, and these differences should be considered in approaching this population.</p></sec></body><back><fn-group><fn fn-type="other"><p><bold>Statements and Declarations:</bold> The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest in the subject matter or materials discussed in this manuscript.</p></fn><fn fn-type="other"><p><bold>Authors contributions:</bold> SLW: conception of the research, data collection, statistical analyses, writing and reviewing of manuscript; AMT: data collection and writing and reviewing of manuscript; MVIS: data collection and manuscript collaboration; AEM: manuscript review; MASC: conception of the research and manuscript review.</p></fn><fn fn-type="COI-statement"><p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The authors received no financial support for the research, authorship, and/or publication of this article.</p></fn><fn fn-type="other"><p><bold>ORCID iD:</bold> Alexandre Mestre Tejo <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-7083-9464" ext-link-type="uri">https://orcid.org/0000-0002-7083-9464</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-23259582241241169"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>Q-L</given-names></name></person-group>. <article-title>The frailty syndrome: Definition and natural history</article-title>. <source>Clin Geriatr Med</source>. <year>2011</year>;<volume>27</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>15</lpage>.<pub-id pub-id-type="pmid">21093718</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cger.2010.08.009</pub-id><pub-id pub-id-type="pmcid">PMC3028599</pub-id></mixed-citation></ref><ref id="bibr2-23259582241241169"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guaraldi</surname><given-names>G</given-names></name><name name-style="western"><surname>Orlando</surname><given-names>G</given-names></name><name name-style="western"><surname>Zona</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal><article-title>Premature age-related comorbidities among HIV-infected persons compared with the general population</article-title>. <source>Clin Infect Dis</source>. <year>2011</year>;<volume>53</volume>(<issue>11</issue>):<fpage>1120</fpage>-<lpage>1126</lpage>.<pub-id pub-id-type="pmid">21998278</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/cir627</pub-id></mixed-citation></ref><ref id="bibr3-23259582241241169"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fried</surname><given-names>LP</given-names></name><name name-style="western"><surname>Tangen</surname><given-names>CM</given-names></name><name name-style="western"><surname>Walston</surname><given-names>J</given-names></name></person-group>, <etal>et al.</etal><article-title>Frailty in older adults: Evidence for a phenotype</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>. <year>2001</year>;<volume>56</volume>(<issue>3</issue>):<comment>M146</comment>-<lpage>M156</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/gerona/56.3.m146</pub-id><pub-id pub-id-type="pmid">11253156</pub-id></mixed-citation></ref><ref id="bibr4-23259582241241169"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoogendijk</surname><given-names>EO</given-names></name><name name-style="western"><surname>van Kan</surname><given-names>GA</given-names></name><name name-style="western"><surname>Guyonnet</surname><given-names>S</given-names></name><name name-style="western"><surname>Vellas</surname><given-names>B</given-names></name><name name-style="western"><surname>Cesari</surname><given-names>M</given-names></name></person-group>. <article-title>Components of the frailty phenotype in relation to the frailty index: Results from the Toulouse frailty platform</article-title>. <source>J Am Med Dir Assoc</source>. <year>2015</year>;<volume>16</volume>(<issue>10</issue>):<fpage>855</fpage>-<lpage>859</lpage>.<pub-id pub-id-type="pmid">25979777</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jamda.2015.04.007</pub-id></mixed-citation></ref><ref id="bibr5-23259582241241169"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kehler</surname><given-names>DS</given-names></name><name name-style="western"><surname>Milic</surname><given-names>J</given-names></name><name name-style="western"><surname>Guaraldi</surname><given-names>G</given-names></name><name name-style="western"><surname>Fulop</surname><given-names>T</given-names></name><name name-style="western"><surname>Falutz</surname><given-names>J</given-names></name></person-group>. <article-title>Frailty in older people living with HIV: Current status and clinical management</article-title>. <source>BMC Geriatr</source>. <year>2022</year>;<volume>22</volume>(<issue>1</issue>):<fpage>919</fpage>.<pub-id pub-id-type="pmid">36447144</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12877-022-03477-7</pub-id><pub-id pub-id-type="pmcid">PMC9708514</pub-id></mixed-citation></ref><ref id="bibr6-23259582241241169"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Condo</surname><given-names>A</given-names></name></person-group>, <etal>et al.</etal><article-title>Prevalence of frailty and prefrailty in people with human immunodeficiency virus aged 50 or older: A systematic review and meta-analysis</article-title>. <source>Open Forum Infect Dis</source>. <year>2022</year>;<volume>9</volume>(<issue>5</issue>):<comment>ofac129</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ofid/ofac129</pub-id><pub-id pub-id-type="pmcid">PMC8995074</pub-id><pub-id pub-id-type="pmid">35415198</pub-id></mixed-citation></ref><ref id="bibr7-23259582241241169"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erlandson</surname><given-names>KM</given-names></name><name name-style="western"><surname>Piggott</surname><given-names>DA</given-names></name></person-group>. <article-title>Frailty and HIV: Moving from characterization to intervention</article-title>. <source>Curr HIV/AIDS Rep</source>. <year>2021</year>;<volume>18</volume>(<issue>3</issue>):<fpage>157</fpage>-<lpage>175</lpage>.<pub-id pub-id-type="pmid">33817767</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11904-021-00554-1</pub-id><pub-id pub-id-type="pmcid">PMC8193917</pub-id></mixed-citation></ref><ref id="bibr8-23259582241241169"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Batistoni</surname><given-names>SST</given-names></name><name name-style="western"><surname>Neri</surname><given-names>AL</given-names></name><name name-style="western"><surname>Cupertino</surname><given-names>APFB</given-names></name></person-group>. <article-title>Validity of the center for epidemiological studies depression scale among</article-title>. <source>Brazilian Elderly Rev Saude Publica</source>. <year>2007</year>;<volume>41</volume>(<issue>4</issue>):<fpage>598</fpage>-<lpage>605</lpage>.<pub-id pub-id-type="pmid">17589758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/s0034-89102007000400014</pub-id></mixed-citation></ref><ref id="bibr9-23259582241241169"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lustosa</surname><given-names>LP</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>DS</given-names></name><name name-style="western"><surname>Dias</surname><given-names>RC</given-names></name><name name-style="western"><surname>Britto</surname><given-names>RR</given-names></name><name name-style="western"><surname>Parentoni</surname><given-names>NA</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>L</given-names></name></person-group>. <article-title>Translation and cross-cultural adaptation of the Minnesota leisure time activities questionnaire in the elderly</article-title>. <source>Geriatr Gerontol</source>. <year>2011</year>;<volume>5</volume>(<issue>2</issue>):<fpage>65</fpage>-<lpage>65</lpage>.</mixed-citation></ref><ref id="bibr10-23259582241241169"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Francesco</surname><given-names>D</given-names></name><name name-style="western"><surname>Sabin</surname><given-names>CA</given-names></name><name name-style="western"><surname>Reiss</surname><given-names>P</given-names></name></person-group>. <article-title>Multimorbidity patterns in people with HIV</article-title>. <source>Curr Opin HIV AIDS</source>. <year>2020</year>;<volume>15</volume>(<issue>2</issue>):<fpage>110</fpage>-<lpage>117</lpage>.<pub-id pub-id-type="pmid">31644480</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/COH.0000000000000595</pub-id></mixed-citation></ref><ref id="bibr11-23259582241241169"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guaraldi</surname><given-names>G</given-names></name><name name-style="western"><surname>Menozzi</surname><given-names>M</given-names></name><name name-style="western"><surname>Zona</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal><article-title>Impact of polypharmacy on antiretroviral prescription in people living with HIV</article-title>. <source>J Antimicrob Chemother</source>. <year>2017</year>;<volume>72</volume>(<issue>2</issue>):<fpage>511</fpage>-<lpage>514</lpage>.<pub-id pub-id-type="pmid">27834193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/dkw437</pub-id></mixed-citation></ref><ref id="bibr12-23259582241241169"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peres</surname><given-names>MA</given-names></name><name name-style="western"><surname>Barbato</surname><given-names>PR</given-names></name><name name-style="western"><surname>Reis</surname><given-names>SCGB</given-names></name><name name-style="western"><surname>Freitas CHS de</surname><given-names>M</given-names></name><name name-style="western"><surname>Antunes</surname><given-names>JLF</given-names></name></person-group>. <article-title>Perdas dent&#225;rias no brasil: An&#225;lise da pesquisa nacional de sa&#250;de bucal 2010</article-title>. <source>Rev Saude Publica</source>. <year>2013</year>;<volume>47</volume>(<issue>Suppl 3</issue>):<fpage>78</fpage>-<lpage>89</lpage>.<pub-id pub-id-type="pmid">24626584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/s0034-8910.2013047004226</pub-id></mixed-citation></ref><ref id="bibr13-23259582241241169"><label>13</label><mixed-citation publication-type="other"><collab>European AIDS Clinical Society/EACS</collab>. <comment>Portuguese version. Available in</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.eacsociety.org/media/guidelines-10.0-portuguese.pdf" ext-link-type="uri">https://www.eacsociety.org/media/guidelines-10.0-portuguese.pdf</ext-link>. <comment>Accessed November, 2019</comment>.</mixed-citation></ref><ref id="bibr14-23259582241241169"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Folstein</surname><given-names>MF</given-names></name><name name-style="western"><surname>Folstein</surname><given-names>SE</given-names></name><name name-style="western"><surname>McHugh</surname><given-names>PR</given-names></name></person-group>. <article-title>Mini-mental state&#8221;. A practical method for grading the cognitive state of patients for the clinician</article-title>. <source>J Psychiatr Res</source>. <year>1975</year>;<volume>12</volume>(<issue>3</issue>):<fpage>189</fpage>-<lpage>198</lpage>.<pub-id pub-id-type="pmid">1202204</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0022-3956(75)90026-6</pub-id></mixed-citation></ref><ref id="bibr15-23259582241241169"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lorenz</surname><given-names>DR</given-names></name><name name-style="western"><surname>Mukerji</surname><given-names>SS</given-names></name><name name-style="western"><surname>Misra</surname><given-names>V</given-names></name></person-group>, <etal>et al.</etal><article-title>Predictors of transition to frailty in middle-aged and older people with HIV: A prospective cohort study: A prospective cohort study</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2021</year>;<volume>88</volume>(<issue>5</issue>):<fpage>518</fpage>-<lpage>527</lpage>.<pub-id pub-id-type="pmid">34757975</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAI.0000000000002810</pub-id><pub-id pub-id-type="pmcid">PMC8589117</pub-id></mixed-citation></ref><ref id="bibr16-23259582241241169"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Hoover</surname><given-names>DR</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Q</given-names></name></person-group>, <etal>et al.</etal><article-title>Frailty as a predictor of falls in HIV-infected and uninfected women</article-title>. <source>Antivir Ther</source>. <year>2019</year>;<volume>24</volume>(<issue>1</issue>):<fpage>51</fpage>-<lpage>61</lpage>.<pub-id pub-id-type="pmid">30604692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3851/IMP3286</pub-id><pub-id pub-id-type="pmcid">PMC10141570</pub-id></mixed-citation></ref><ref id="bibr17-23259582241241169"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mickute</surname><given-names>M</given-names></name><name name-style="western"><surname>Zaccardi</surname><given-names>F</given-names></name><name name-style="western"><surname>Razieh</surname><given-names>C</given-names></name></person-group>, <etal>et al.</etal><article-title>Individual frailty phenotype components and mortality in adults with type 2 diabetes: A UK biobank study</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2023</year>;<volume>195</volume>(<issue>110155</issue>):<fpage>110155</fpage>.<pub-id pub-id-type="pmid">36427627</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.diabres.2022.110155</pub-id></mixed-citation></ref><ref id="bibr18-23259582241241169"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andrade</surname><given-names>JM</given-names></name><name name-style="western"><surname>Duarte YA de</surname><given-names>O</given-names></name><name name-style="western"><surname>Alves</surname><given-names>LC</given-names></name></person-group>, <etal>et al.</etal><article-title>Frailty profile in Brazilian older adults: ELSI-Brazil</article-title>. <source>Rev Saude Publica</source>. <year>2018</year>;<volume>52</volume>(Suppl <issue>2</issue>):17 s.<pub-id pub-id-type="doi" assigning-authority="pmc">10.11606/S1518-8787.2018052000616</pub-id><pub-id pub-id-type="pmcid">PMC6255048</pub-id><pub-id pub-id-type="pmid">30379282</pub-id></mixed-citation></ref><ref id="bibr19-23259582241241169"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erlandson</surname><given-names>KM</given-names></name><name name-style="western"><surname>Allshouse</surname><given-names>AA</given-names></name><name name-style="western"><surname>Jankowski</surname><given-names>CM</given-names></name></person-group>, <etal>et al.</etal><article-title>Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy</article-title>. <source>HIV Clin Trials</source>. <year>2012</year>;<volume>13</volume>(<issue>6</issue>):<fpage>324</fpage>-<lpage>334</lpage>.<pub-id pub-id-type="pmid">23195670</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1310/hct1306-324</pub-id><pub-id pub-id-type="pmcid">PMC4379206</pub-id></mixed-citation></ref><ref id="bibr20-23259582241241169"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bregigeon</surname><given-names>S</given-names></name><name name-style="western"><surname>Galinier</surname><given-names>A</given-names></name><name name-style="western"><surname>Zaegel-Faucher</surname><given-names>O</given-names></name></person-group>, <etal>et al.</etal><article-title>Frailty in HIV infected people: A new risk factor for bone mineral density loss</article-title>. <source>AIDS</source>. <year>2017</year>;<volume>31</volume>(<issue>11</issue>):<fpage>1573</fpage>-<lpage>1577</lpage>.<pub-id pub-id-type="pmid">28426535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000001507</pub-id></mixed-citation></ref><ref id="bibr21-23259582241241169"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>RH</given-names></name><name name-style="western"><surname>Cooley</surname><given-names>SA</given-names></name><name name-style="western"><surname>Garcia-Egan</surname><given-names>PM</given-names></name><name name-style="western"><surname>Ances</surname><given-names>BM</given-names></name></person-group>. <article-title>Cognitive performance and frailty in older HIV-positive adults</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2018</year>;<volume>79</volume>(<issue>3</issue>):<fpage>375</fpage>-<lpage>380</lpage>.<pub-id pub-id-type="pmid">29957675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAI.0000000000001790</pub-id><pub-id pub-id-type="pmcid">PMC10733865</pub-id></mixed-citation></ref><ref id="bibr22-23259582241241169"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petit</surname><given-names>N</given-names></name><name name-style="western"><surname>Enel</surname><given-names>P</given-names></name><name name-style="western"><surname>Ravaux</surname><given-names>I</given-names></name></person-group>, <etal>et al.</etal><article-title>Frail and pre-frail phenotype is associated with pain in older HIV-infected patients</article-title>. <source>Medicine (Baltimore)</source>. <year>2018</year>;<volume>97</volume>(<issue>6</issue>):<comment>e9852</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000009852</pub-id><pub-id pub-id-type="pmcid">PMC5944687</pub-id><pub-id pub-id-type="pmid">29419697</pub-id></mixed-citation></ref><ref id="bibr23-23259582241241169"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fatukasi</surname><given-names>TV</given-names></name><name name-style="western"><surname>Edmonds</surname><given-names>A</given-names></name><name name-style="western"><surname>Gustafson</surname><given-names>DR</given-names></name></person-group>, <etal>et al.</etal><article-title>Prevalence and 1-year incidence of frailty among women with and without HIV in the women&#8217;s interagency HIV study</article-title>. <source>AIDS</source>. <year>2019</year>;<volume>33</volume>(<issue>2</issue>):<fpage>357</fpage>-<lpage>359</lpage>.<pub-id pub-id-type="pmid">30562174</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000002047</pub-id><pub-id pub-id-type="pmcid">PMC6487202</pub-id></mixed-citation></ref><ref id="bibr24-23259582241241169"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeballos</surname><given-names>D</given-names></name><name name-style="western"><surname>Lins</surname><given-names>L</given-names></name><name name-style="western"><surname>Brites</surname><given-names>C</given-names></name></person-group>. <article-title>Frailty and its association with health related quality of life in older HIV patients, in Salvador, Brazil</article-title>. <source>AIDS Res Hum Retroviruses</source>. <year>2019</year>;<volume>35</volume>(<issue>11</issue>-<issue>12</issue>):<fpage>1074</fpage>-<lpage>1081</lpage>.<pub-id pub-id-type="pmid">31373215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/AID.2019.0103</pub-id></mixed-citation></ref><ref id="bibr25-23259582241241169"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smit</surname><given-names>E</given-names></name><name name-style="western"><surname>Wanke</surname><given-names>C</given-names></name><name name-style="western"><surname>Dong</surname><given-names>K</given-names></name></person-group>, <etal>et al.</etal><article-title>Frailty, food insecurity, and nutritional status in people living with HIV</article-title>. <source>J Frailty Aging</source>. <year>2015</year>;<volume>4</volume>(<issue>4</issue>):<fpage>191</fpage>-<lpage>197</lpage>.<pub-id pub-id-type="pmid">26689809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14283/jfa.2015.50</pub-id><pub-id pub-id-type="pmcid">PMC4682910</pub-id></mixed-citation></ref><ref id="bibr26-23259582241241169"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morgello</surname><given-names>S</given-names></name><name name-style="western"><surname>Gensler</surname><given-names>G</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal><article-title>Frailty in medically complex individuals with chronic HIV</article-title>. <source>AIDS</source>. <year>2019</year>;<volume>33</volume>(<issue>10</issue>):<fpage>1603</fpage>-<lpage>1611</lpage>.<pub-id pub-id-type="pmid">31305330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000002250</pub-id><pub-id pub-id-type="pmcid">PMC6760300</pub-id></mixed-citation></ref><ref id="bibr27-23259582241241169"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wulunggono</surname><given-names>W</given-names></name><name name-style="western"><surname>Yunihastuti</surname><given-names>E</given-names></name><name name-style="western"><surname>Shatri</surname><given-names>H</given-names></name><name name-style="western"><surname>Wahyudi</surname><given-names>ER</given-names></name><name name-style="western"><surname>Ophinni</surname><given-names>Y</given-names></name></person-group>. <article-title>Frailty among HIV-1 infected adults under antiretroviral therapy in Indonesia</article-title>. <source>Curr HIV Res</source>. <year>2019</year>;<volume>17</volume>(<issue>3</issue>):<fpage>204</fpage>-<lpage>213</lpage>.<pub-id pub-id-type="pmid">31456523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1570162X17666190828143947</pub-id><pub-id pub-id-type="pmcid">PMC7061977</pub-id></mixed-citation></ref><ref id="bibr28-23259582241241169"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsakona</surname><given-names>D</given-names></name><name name-style="western"><surname>Kapetanakis</surname><given-names>A</given-names></name><name name-style="western"><surname>Kyrou</surname><given-names>D</given-names></name></person-group>, <etal>et al.</etal><article-title>Mapping frailty in people living with HIV: A nationwide study in Greece</article-title>. <source>HIV Med</source>. <year>2023</year>;<volume>24</volume>(<issue>2</issue>):<fpage>170</fpage>-<lpage>179</lpage>.<pub-id pub-id-type="pmid">35840121</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/hiv.13356</pub-id></mixed-citation></ref><ref id="bibr29-23259582241241169"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H</given-names></name></person-group>, <etal>et al.</etal><article-title>Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?</article-title><source>HIV Med</source>. <year>2023</year>;<volume>24</volume>(5):533-543. doi:<pub-id pub-id-type="doi">10.1111/hiv.13429</pub-id>. Epub 2022 Oct 26. PMID: 36288971.<pub-id pub-id-type="pmid">36288971</pub-id></mixed-citation></ref><ref id="bibr30-23259582241241169"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allavena</surname><given-names>C</given-names></name><name name-style="western"><surname>Blain</surname><given-names>H</given-names></name><name name-style="western"><surname>Abulizi</surname><given-names>X</given-names></name></person-group>, <etal>et al.</etal><article-title>Prevalence and risk factors of frailty among adults living with HIV aged 70 years or older</article-title>. <source>AIDS</source>. <year>2023</year>;<volume>37</volume>(<issue>1</issue>):<fpage>183</fpage>-<lpage>189</lpage>.<pub-id pub-id-type="pmid">36250271</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000003403</pub-id></mixed-citation></ref><ref id="bibr31-23259582241241169"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pathai</surname><given-names>S</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>C</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>HA</given-names></name></person-group>, <etal>et al.</etal><article-title>Frailty in HIV-infected adults in South Africa</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2013</year>;<volume>62</volume>(<issue>1</issue>):<fpage>43</fpage>-<lpage>51</lpage>.<pub-id pub-id-type="pmid">23018372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAI.0b013e318273b631</pub-id><pub-id pub-id-type="pmcid">PMC3772340</pub-id></mixed-citation></ref><ref id="bibr32-23259582241241169"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kooij</surname><given-names>KW</given-names></name><name name-style="western"><surname>Wit</surname><given-names>FWNM</given-names></name><name name-style="western"><surname>Schouten</surname><given-names>J</given-names></name></person-group>, <etal>et al.</etal><article-title>HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls</article-title>. <source>AIDS</source>. <year>2016</year>;<volume>30</volume>(<issue>2</issue>):<fpage>241</fpage>-<lpage>250</lpage>.<pub-id pub-id-type="pmid">26684821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000000910</pub-id></mixed-citation></ref><ref id="bibr33-23259582241241169"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Theou</surname><given-names>O</given-names></name><name name-style="western"><surname>Cann</surname><given-names>L</given-names></name><name name-style="western"><surname>Blodgett</surname><given-names>J</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>LMK</given-names></name><name name-style="western"><surname>Brothers</surname><given-names>TD</given-names></name><name name-style="western"><surname>Rockwood</surname><given-names>K</given-names></name></person-group>. <article-title>Modifications to the frailty phenotype criteria: Systematic review of the current literature and investigation of 262 frailty phenotypes in the survey of health, ageing, and retirement in Europe</article-title>. <source>Ageing Res Rev</source>. <year>2015</year>;<volume>21</volume>:<fpage>78</fpage>-<lpage>94</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arr.2015.04.001</pub-id>. Epub 2015 Apr 4. PMID: 25846451.<pub-id pub-id-type="pmid">25846451</pub-id></mixed-citation></ref><ref id="bibr34-23259582241241169"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ziller</surname><given-names>C</given-names></name><name name-style="western"><surname>Braun</surname><given-names>T</given-names></name><name name-style="western"><surname>Thiel</surname><given-names>C</given-names></name></person-group>. <article-title>Frailty phenotype prevalence in community-dwelling older adults according to physical activity assessment method</article-title>. <source>Clin Interv Aging</source>. <year>2020</year>;<volume>15</volume>:<fpage>343</fpage>-<lpage>355</lpage>.<pub-id pub-id-type="pmid">32210545</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/CIA.S238204</pub-id><pub-id pub-id-type="pmcid">PMC7069579</pub-id></mixed-citation></ref><ref id="bibr35-23259582241241169"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vancampfort</surname><given-names>D</given-names></name><name name-style="western"><surname>Mugisha</surname><given-names>J</given-names></name><name name-style="western"><surname>De Hert</surname><given-names>M</given-names></name><name name-style="western"><surname>Probst</surname><given-names>M</given-names></name><name name-style="western"><surname>Stubbs</surname><given-names>B.</given-names></name></person-group><article-title>Sedentary behavior in people living with HIV: A systematic review and meta-analysis</article-title>. <source>J Phys Act Health</source>. <year>2017</year>;<volume>14</volume>(<issue>7</issue>):<fpage>571</fpage>-<lpage>577</lpage>. doi:<pub-id pub-id-type="doi">10.1123/jpah.2016-0507</pub-id>. Epub 2017 Mar 14. PMID: 28290767.<pub-id pub-id-type="pmid">28290767</pub-id></mixed-citation></ref><ref id="bibr36-23259582241241169"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tegene</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mengesha</surname><given-names>S</given-names></name><name name-style="western"><surname>van der Starre</surname><given-names>C</given-names></name><name name-style="western"><surname>Lako</surname><given-names>S</given-names></name><name name-style="western"><surname>Toma</surname><given-names>A</given-names></name><name name-style="western"><surname>Spigt</surname><given-names>M</given-names></name></person-group>. <article-title>Physical activity level and associated factors among adult HIV patients in Ethiopia</article-title>. <source>BMC Infect Dis</source>. <year>2022</year>;<volume>22</volume>(<issue>1</issue>):<fpage>123</fpage>.<pub-id pub-id-type="pmid">35120443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-022-07120-z</pub-id><pub-id pub-id-type="pmcid">PMC8817526</pub-id></mixed-citation></ref><ref id="bibr37-23259582241241169"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Payne</surname><given-names>BAI</given-names></name><name name-style="western"><surname>Hateley</surname><given-names>CL</given-names></name><name name-style="western"><surname>Ong</surname><given-names>ELC</given-names></name></person-group>, <etal>et al.</etal><article-title>HIV-associated fatigue in the era of highly active antiretroviral therapy: Novel biological mechanisms?: Fatigue and HIV</article-title>. <source>HIV Med</source>. <year>2013</year>;<volume>14</volume>(<issue>4</issue>):<fpage>247</fpage>-<lpage>251</lpage>.<pub-id pub-id-type="pmid">22998022</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1468-1293.2012.01050.x</pub-id></mixed-citation></ref><ref id="bibr38-23259582241241169"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barroso</surname><given-names>J</given-names></name><name name-style="western"><surname>Leserman</surname><given-names>J</given-names></name><name name-style="western"><surname>Harmon</surname><given-names>JL</given-names></name><name name-style="western"><surname>Hammill</surname><given-names>B</given-names></name><name name-style="western"><surname>Pence</surname><given-names>BW</given-names></name></person-group>. <article-title>Fatigue in HIV-infected people: A three-year observational study</article-title>. <source>J Pain Symptom Manage</source>. <year>2015</year>;<volume>50</volume>(<issue>1</issue>):<fpage>69</fpage>-<lpage>79</lpage>.<pub-id pub-id-type="pmid">25701691</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpainsymman.2015.02.006</pub-id><pub-id pub-id-type="pmcid">PMC4492863</pub-id></mixed-citation></ref><ref id="bibr39-23259582241241169"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dodds</surname><given-names>RM</given-names></name><name name-style="western"><surname>Syddall</surname><given-names>HE</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>R</given-names></name></person-group>, <etal>et al.</etal><article-title>Grip strength across the life course: Normative data from twelve British studies</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>(<issue>12</issue>):<comment>e113637</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0113637</pub-id><pub-id pub-id-type="pmcid">PMC4256164</pub-id><pub-id pub-id-type="pmid">25474696</pub-id></mixed-citation></ref><ref id="bibr40-23259582241241169"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dos-Santos-Quaresma</surname><given-names>MVL</given-names></name><name name-style="western"><surname>Lima-Ribeiro</surname><given-names>SM</given-names></name></person-group>. <article-title>Sarcopenia in persons living with HIV under antiretroviral therapy: Literature review</article-title>. <source>AIDS Rev</source>. <year>2022</year>;<volume>24</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>15</lpage>.<pub-id pub-id-type="pmid">34082442</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.24875/AIDSRev.21000018</pub-id></mixed-citation></ref><ref id="bibr41-23259582241241169"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schrack</surname><given-names>JA</given-names></name><name name-style="western"><surname>Jacobson</surname><given-names>LP</given-names></name><name name-style="western"><surname>Althoff</surname><given-names>KN</given-names></name></person-group>, <etal>et al.</etal><article-title>Effect of HIV-infection and cumulative viral load on age-related decline in grip strength</article-title>. <source>AIDS</source>. <year>2016</year>;<volume>30</volume>(<issue>17</issue>):<fpage>2645</fpage>-<lpage>2652</lpage>.<pub-id pub-id-type="pmid">27603294</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000001245</pub-id><pub-id pub-id-type="pmcid">PMC5083134</pub-id></mixed-citation></ref><ref id="bibr42-23259582241241169"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>VH</given-names></name><name name-style="western"><surname>Wiechmann</surname><given-names>SL</given-names></name><name name-style="western"><surname>Narciso</surname><given-names>AM</given-names></name><name name-style="western"><surname>Webel</surname><given-names>AR</given-names></name><name name-style="western"><surname>Deminice</surname><given-names>R</given-names></name></person-group>. <article-title>Muscle strength is impaired in men but not in women living with HIV taking antiretroviral therapy</article-title>. <source>Antivir Ther</source>. <year>2018</year>;<volume>23</volume>(<issue>1</issue>):<fpage>11</fpage>-<lpage>19</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3851/IMP3159</pub-id><pub-id pub-id-type="pmid">28327461</pub-id></mixed-citation></ref><ref id="bibr43-23259582241241169"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lakey</surname><given-names>W</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L-Y</given-names></name><name name-style="western"><surname>Chow</surname><given-names>Yancy W</given-names></name><name name-style="western"><surname>Hicks</surname><given-names>S-C</given-names></name></person-group><comment>C.</comment><article-title>Short communication: From wasting to obesity: Initial antiretroviral therapy and weight gain in HIV-infected persons</article-title>. <source>AIDS Res Hum Retroviruses</source>. <year>2013</year>;<volume>29</volume>(<issue>3</issue>):<fpage>435</fpage>-<lpage>440</lpage>.<pub-id pub-id-type="pmid">23072344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/aid.2012.0234</pub-id><pub-id pub-id-type="pmcid">PMC3581041</pub-id></mixed-citation></ref><ref id="bibr44-23259582241241169"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schrack</surname><given-names>JA</given-names></name><name name-style="western"><surname>Althoff</surname><given-names>KN</given-names></name><name name-style="western"><surname>Jacobson</surname><given-names>LP</given-names></name></person-group>, <etal>et al.</etal><article-title>Accelerated longitudinal gait speed decline in HIV-infected older men</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2015</year>;<volume>70</volume>(<issue>4</issue>):<fpage>370</fpage>-<lpage>376</lpage>.<pub-id pub-id-type="pmid">26102450</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAI.0000000000000731</pub-id><pub-id pub-id-type="pmcid">PMC4624470</pub-id></mixed-citation></ref><ref id="bibr45-23259582241241169"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>HT</given-names></name><name name-style="western"><surname>Levett</surname><given-names>T</given-names></name><name name-style="western"><surname>Barber</surname><given-names>TJ.</given-names></name></person-group><article-title>Frailty in people living with HIV: An update: An update</article-title>. <source>Curr Opin Infect Dis</source><comment>[Internet]</comment>. <year>2022</year>;<volume>35</volume>(<issue>1</issue>):<fpage>21</fpage>-<lpage>30</lpage>. <comment>Dispon&#237;vel em</comment>:<pub-id pub-id-type="pmid">34799510</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QCO.0000000000000798</pub-id></mixed-citation></ref><ref id="bibr46-23259582241241169"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsieh</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Chang</surname><given-names>HY</given-names></name><name name-style="western"><surname>Wu</surname><given-names>IC</given-names></name></person-group>, <etal>et al.</etal><article-title>Independent association between subjective cognitive decline and frailty in the elderly</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>8</issue>):<comment>e0201351</comment>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0201351</pub-id><pub-id pub-id-type="pmcid">PMC6072005</pub-id><pub-id pub-id-type="pmid">30071051</pub-id></mixed-citation></ref><ref id="bibr47-23259582241241169"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guaraldi</surname><given-names>G</given-names></name><name name-style="western"><surname>Milic</surname><given-names>J</given-names></name><name name-style="western"><surname>Mussini</surname><given-names>C</given-names></name></person-group>. <article-title>Aging with HIV</article-title>. <source>Curr HIV/AIDS Rep</source>. <year>2019</year>;<volume>16</volume>(<issue>6</issue>):<fpage>475</fpage>-<lpage>481</lpage>.<pub-id pub-id-type="pmid">31823125</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11904-019-00464-3</pub-id></mixed-citation></ref><ref id="bibr48-23259582241241169"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garner</surname><given-names>IW</given-names></name><name name-style="western"><surname>Varey</surname><given-names>S</given-names></name><name name-style="western"><surname>Navarro-Pardo</surname><given-names>E</given-names></name><name name-style="western"><surname>Marr</surname><given-names>C</given-names></name><name name-style="western"><surname>Holland</surname><given-names>CA</given-names></name></person-group>. <article-title>An observational cohort study of longitudinal impacts on frailty and well-being of COVID-19 lockdowns in older adults in England and Spain</article-title>. <source>Health Soc Care Community</source>. <year>2022</year>;<volume>30</volume>(<issue>5</issue>):<comment>e2905</comment>-<lpage>e2916</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/hsc.13735</pub-id><pub-id pub-id-type="pmcid">PMC9545919</pub-id><pub-id pub-id-type="pmid">35089638</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>